Fate Receives $4 Million to Advance Natural Killer Cell Immunotherapy Into Trials – Immuno-Oncology News
Immuno-Oncology News |
Fate Receives $4 Million to Advance Natural Killer Cell Immunotherapy Into Trials
Immuno-Oncology News At the heart of Fate's therapy is engineering white blood cells known as natural killer cells to do a better job of killing tumor cells. Natural killer cells play a key role in preventing and eliminating tumor cells. Once immune system antibodies bind … |
